Add-On Dupilumab for COPD Backed by Second Phase III Trial

NOTUS study confirms fewer exacerbations with biologic for patients on maximum inhaled therapy

Related Keywords

United States ,American , ,Ppamerican Thoracic Society ,Thoracic Society ,New England Journal ,Medpage Today ,American Indian ,Alaska Native ,Respiratory Questionnaire ,Evaluating Respiratory Symptoms ,England Journal ,Englj Med ,